|
Antibody
Approved
Unknown
Unknown
Kidney Neoplasms; Esophageal Neoplasms; Hematologic Neoplasms; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Multiple Myeloma; Myelodysplastic Syndromes; Peritoneal Neoplasms; Adenocarcinoma, Follicular; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Colorectal Neoplasms; Dysgerminoma; Fallopian Tube Neoplasms; Genital Neoplasms, Female; Glioblastoma; Head and Neck Neoplasms; HIV Infections; Lung Neoplasms; Mesothelioma; Neoplasms, Germ Cell and Embryonal; Neuroendocrine Tumors; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Sarcoma; Seminoma; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Thyroid Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Melanoma; Neoplasms; Small Cell Lung Carcinoma; Urinary Bladder Neoplasms; Urogenital Neoplasms
Cytotoxic T-lymphocyte protein 4 inhibitor
|
